Why Does Cantor Fitzgerald See Over 1,000% Potential Upside For Cabaletta Bio Stock?
The analyst noted that Auto-CAR-T is showing unprecedented and transformational efficacy in systemic sclerosis, and investors aren't appreciating the substantial unmet need this represents.